Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 11, 2018 - Issue
Submit an article Journal homepage
166
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder

Mikhail Sergeevich Zastrozhin1 Department of Addictology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia,[email protected];2 Department of Addictology, Moscow Research and Practical Center on Addictions, Moscow, Russia, [email protected]Correspondence[email protected]
,
Elena Anatolievna Grishina3 Research Centre, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Research Centre, Moscow, Russia
,
Nataliya Petrovna Denisenko3 Research Centre, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Research Centre, Moscow, Russia
,
Valentin Yurievich Skryabin2 Department of Addictology, Moscow Research and Practical Center on Addictions, Moscow, Russia, [email protected]
,
Dmitry Dmitrievich Markov3 Research Centre, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Research Centre, Moscow, Russia
,
Ludmila Mikhailovna Savchenko1 Department of Addictology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia,[email protected]
,
Evgeny Alekseevich Bryun1 Department of Addictology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia,[email protected];2 Department of Addictology, Moscow Research and Practical Center on Addictions, Moscow, Russia, [email protected]
&
Dmitry Alekseevich Sychev4 Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia
 show all
Pages 113-119 | Published online: 29 Jun 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Min Liu, Xiaoli Shen, Xixun Du & Hong Jiang. (2020) Plasma levels of nesfatin-1 as a new biomarker in depression in Asians: evidence from meta-analysis. Biomarkers 25:3, pages 228-234.
Read now

Articles from other publishers (8)

V. Yu. Skryabin, M. S. Zastrozhin, E. A. Grishina, K. A. Ryzhikova, V. V. Shipitsyn, T. E. Galaktionova, E. A. Bryun & D. A. Sychev. (2021) Relations of CYP2C19*2 genetic polymorphisms to plasma and saliva concentrations of diazepam in patients hospitalized for alcohol withdrawal. Personalized Psychiatry and Neurology 1:1, pages 84-92.
Crossref
D. A. Sychev & L. K. Moshetova. (2020) Problems of integrating medical science, image and practical health care: focus on personalized medicine. Pharmacogenetics and Pharmacogenomics:1, pages 3-10.
Crossref
М.С. Застрожин, Е.А. Гришина, К.А. Рыжикова, В.Ю. Скрябин, С.Г. Копоров, Е.А. Брюн & Д.А. Сычев. (2020) The Impact of Polymorphisms ABCB1 on the Effectivenessand Safety of Fluvoxamine in Patients with Depressive Disorder with Comorbid Alcoholism. Психиатрия, психотерапия и клиническая психология:3, pages 570-577.
Crossref
Juncai Xin, Meng Yuan, Yonglin Peng & Ju Wang. (2020) Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder. Frontiers in Psychiatry 11.
Crossref
Mikhail Zastrozhin, Valentin Skryabin, Kristina Ryzhikova & Dmitriy Sychev. (2020) Assessment of the impact of the steady state level of microRNA hsa-miR-370-3p concentration on the efficacy and safety profile of fluvoxamine in patients with depressive disorders disorder comorbid with alcohol use disorders. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery):2, pages 37-46.
Crossref
M.S. ZastrozhinV.Y. SkryabinV.V. SmirnovE.A. GrishinaK.A. RyzhikovaE.M. ChumakovE.A. BryunD.A. Sychev. (2019) Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder. Canadian Journal of Physiology and Pharmacology 97:8, pages 781-785.
Crossref
Mikhail S. Zastrozhin, Valery V. Smirnov, Alexander S. Sorokin, Elena A. Grishina, Kristina A. Ryzhikova, Valery V. Shipitsyn, Ludmila M. Savchenko, Oleg Z. Buzik, Sergey S. Koporov, Evgeny A. Bryun & Dmitry A. Sychev. (2019) The Effect of Cyp2d6 Gene Polymorphism on the Efficacy and Safety of Mirtazapine in Patients with Depressive Disorders Comorbid with Alcohol. Annals of the Russian academy of medical sciences 74:3, pages 185-191.
Crossref
Mikhail S. Zastrozhin, Valery V. Smirnov, Alexander S. Sorokin, Elena A. Grishina, Kristina A. Ryzhikova, Inessa A. Bedina, Valery V. Shipitsyn, Ludmila M. Savchenko, Oleg Zh. Buzik, Sergey S. Koporov, Evgeny А. Bryun & Dmitry A. Sychev. (2018) Influence of CYP3A Activity on the Efficacy and Safety of Fluvoxamine in Patients Depressive Disorders and Comorbid Alcohol Use Disorder. Annals of the Russian academy of medical sciences 73:6, pages 411-419.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.